Genetic Technologies Ltd has released a press release.
Launch of test for 100% risk of breast and ovarian cancer
Filed with ASX ·
6ix hasn’t read this filing yet.
Genetic Technologies Limited on 6ix
Earlier from Genetic Technologies
- GTG and Wellworks for You sign B2B sales and marketing deal
- Prospectus Supplement
- GTG announces US$2 Million Registered Direct Offering
- GTG Announces New Precision Oncology Tests
- GTG to pilot GeneType in Breast Screen centres across the US
Later from Genetic Technologies
- GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer
- GeneType and Stayhealthy Announce Landmark Distribution Agre
- GTG Expands Operational Capacity in North America
- Genetic Technologies Expands Operational Capacity in North America
- GeneType identifies 79.5% at risk of serious disease
Follow Genetic Technologies into a list and get an email when it puts out news.
Follow Genetic Technologies